Literature DB >> 22856340

Signal-morphology impedance cardiography during incremental cardiopulmonary exercise testing in pulmonary arterial hypertension.

Eloara M Ferreira1, Jaquelina S Ota-Arakaki, Priscila B Barbosa, Ana Cristina B Siqueira, Daniela M Bravo, Carlos Eduardo B Kapins, Célia Maria C Silva, Luiz Eduardo Nery, J Alberto Neder.   

Abstract

BACKGROUND: Haemodynamic responses to exercise are related to physical impairment and worse prognosis in patients with pulmonary arterial hypertension (PAH). It is clinically relevant, therefore, to investigate the practical usefulness of non-invasive methods of monitoring exercise haemodynamics in this patient population.
METHODS: Using a novel impedance cardiography (ICG) approach that does not require basal impedance estimations and relies on a morphological analysis of the impedance signal (Signal-Morphology-ICG(™)), stroke volume (SV) and cardiac index (CI) were evaluated in 50 patients and 21 age-matched controls during a ramp-incremental cardiopulmonary exercise testing.
RESULTS: Technically unacceptable readings were found in 12 of 50 (24%) patients. In the remaining subjects, early decrease (N = 9) or a 'plateau' in SV (N = 8) and Δ (peak-unloaded exercise) SV <10 ml were markers of more advanced PAH (P<0.05). ΔCI ≤ 1.5-fold and early estimated lactate threshold were the only independent predictors of a severely reduced peak oxygen uptake (VO(2)) in patients (R(2) = 0.71, P<0.001). The finding of ΔCI ≤ 1.5-fold plus peak VO(2) < 50% predicted was associated with a number of clinical and functional markers of disease severity (P<0.001). In addition, abnormal SV responses and ΔCI ≤ 1.5-fold were significantly related to 1-year frequency of PAH-related adverse events (death and balloon atrial septostomy, N = 8; P<0.05).
CONCLUSIONS: 'Qualitative' and 'semi-quantitative' signal-morphology impedance cardiography(™) (PhysioFlow(™)) during incremental exercise provided clinically useful information to estimate disease severity and short-term prognosis in patients with PAH in whom acceptable impedance signals could be obtained.
© 2012 The Authors Clinical Physiology and Functional Imaging © 2012 Scandinavian Society of Clinical Physiology and Nuclear Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22856340     DOI: 10.1111/j.1475-097X.2012.01135.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  6 in total

1.  Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.

Authors:  Adriano R Tonelli; Laith Alkukhun; Vineesha Arelli; José Ramos; Jennie Newman; Kevin McCarthy; Bohdan Pichurko; Omar A Minai; Raed A Dweik
Journal:  Clin Transl Sci       Date:  2013-09-06       Impact factor: 4.689

2.  Exercise Capacity and Quality of Life in Pulmonary Arterial Hypertension.

Authors:  Ling-Wei Chen; Ssu-Yuan Chen; Hsao-Hsun Hsu; Yen-Wen Wu; Yu-Mei Lai; Meng-Yueh Chien
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

3.  Noninvasive investigation of the cardiodynamic response to 6MWT in people after stroke using impedance cardiography.

Authors:  Fang Liu; Alice Y M Jones; Raymond C C Tsang; Yao Wang; Jing Zhou; Mingchao Zhou; Yulong Wang
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

4.  Stroke volume and cardiac output during 6 minute-walk tests are strong predictors of maximal oxygen uptake in people after stroke.

Authors:  Fang Liu; Alice Y M Jones; Raymond C C Tsang; Fubing Zha; Mingchao Zhou; Kaiwen Xue; Zeyu Zhang; Yulong Wang
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

5.  Cardiodynamic variables measured by impedance cardiography during a 6-minute walk test are reliable predictors of peak oxygen consumption in young healthy adults.

Authors:  Fang Liu; Raymond C C Tsang; Alice Y M Jones; Mingchao Zhou; Kaiwen Xue; Miaoling Chen; Yulong Wang
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

6.  Cardiac hemodynamic response to the 6-minute walk test in young adults and the elderly.

Authors:  Fujiko Someya; Naoki Mugii; Sachie Oohata
Journal:  BMC Res Notes       Date:  2015-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.